These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 31016379)

  • 1. Prognostic significance of C-reactive protein to albumin ratio in colorectal cancer patients: a meta-analysis.
    Fan Y; Xiang S; Dai Z; Zou C; Wang X; Gao Z
    Int J Colorectal Dis; 2019 Jun; 34(6):1105-1111. PubMed ID: 31016379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the C-reactive protein to albumin ratio in esophageal cancer: A systematic review and meta-analysis.
    Wang Y; Hu X; Huang Y; Xu WY; Wu YM; Li PF; Che GW
    Kaohsiung J Med Sci; 2020 Jan; 36(1):54-61. PubMed ID: 31512813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of the C-reactive protein to albumin ratio in colorectal cancer: an updated systematic review and meta-analysis.
    Liao CK; Yu YL; Lin YC; Hsu YJ; Chern YJ; Chiang JM; You JF
    World J Surg Oncol; 2021 May; 19(1):139. PubMed ID: 33933070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of C-reactive protein to albumin ratio in metastatic colorectal cancer: A systematic review and meta-analysis.
    Pan Y; Lou Y; Wang L
    Medicine (Baltimore); 2021 Nov; 100(46):e27783. PubMed ID: 34797305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of pretreatment C-reactive protein/albumin ratio in nasopharyngeal carcinoma: A meta-analysis of published literature.
    Yang X; Liu H; He M; Liu M; Zhou G; Gong P; Ma J; Wang Q; Xiong W; Ren Z; Li X; Zhang X
    Medicine (Baltimore); 2018 Jul; 97(30):e11574. PubMed ID: 30045284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of C-reactive protein to albumin ratio in colorectal cancer: A meta analysis.
    Wang F; Li P; Li FS
    Medicine (Baltimore); 2019 Jul; 98(29):e16064. PubMed ID: 31335668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of the pretreatment C-reactive protein/albumin ratio in gastric cancer: A systematic review and meta-analysis.
    Yang X; Song X; Zhang L; Wu C
    Medicine (Baltimore); 2020 Mar; 99(10):e19362. PubMed ID: 32150079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment C-reactive protein/albumin ratio for predicting overall survival in pancreatic cancer: A meta-analysis.
    Zang Y; Fan Y; Gao Z
    Medicine (Baltimore); 2020 Jun; 99(23):e20595. PubMed ID: 32502031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of C-reactive protein/albumin ratio in human malignancies: an updated meta-analysis.
    Xu HJ; Ma Y; Deng F; Ju WB; Sun XY; Wang H
    Onco Targets Ther; 2017; 10():3059-3070. PubMed ID: 28790840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-Reactive Protein to Albumin Ratio in Colorectal Cancer: A Meta-Analysis of Prognostic Value.
    Zhou QP; Li XJ
    Dose Response; 2019; 17(4):1559325819889814. PubMed ID: 31798355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients With Pancreatic Cancer: A Meta-Analysis.
    Xie Q; Wang L; Zheng S
    Dose Response; 2020; 18(2):1559325820931290. PubMed ID: 32647499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The C-Reactive Protein/Albumin Ratio is a Novel Significant Prognostic Factor in Patients with Malignant Pleural Mesothelioma: A Retrospective Multi-institutional Study.
    Takamori S; Toyokawa G; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Hirai F; Seto T; Tagawa T; Takenoyama M; Ichinose Y; Maehara Y
    Ann Surg Oncol; 2018 Jun; 25(6):1555-1563. PubMed ID: 29500763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of the C-reactive protein to albumin ratio in cancer: An updated meta-analysis.
    Cui X; Jia Z; Chen D; Xu C; Yang P
    Medicine (Baltimore); 2020 Apr; 99(14):e19165. PubMed ID: 32243358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of pre-treatment C-reactive protein/albumin ratio in esophageal cancer: a meta-analysis.
    Liu Z; Shi H; Chen L
    BMC Cancer; 2019 Nov; 19(1):1161. PubMed ID: 31783812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.
    Jiang Y; Gu H; Zheng X; Pan B; Liu P; Zheng M
    Pathol Oncol Res; 2021; 27():1609946. PubMed ID: 34992504
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
    Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Significance of C-Reactive Protein to Albumin Ratio in Patients with Hepatocellular Carcinoma: A Meta-Analysis.
    Lin N; Li J; Ke Q; Wang L; Cao Y; Liu J
    Dis Markers; 2020; 2020():4867974. PubMed ID: 32963635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Role of the Pretreatment C-Reactive Protein/Albumin Ratio in Solid Cancers: A Meta-Analysis.
    Li N; Tian GW; Wang Y; Zhang H; Wang ZH; Li G
    Sci Rep; 2017 Jan; 7():41298. PubMed ID: 28128229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic and prognostic significance of C-reactive protein/albumin ratio in patients with solid tumors: an updated systemic review and meta-analysis.
    Wu J; Tan W; Chen L; Huang Z; Mai S
    Oncotarget; 2018 Mar; 9(17):13934-13947. PubMed ID: 29568406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein to albumin ratio predicts the outcome in renal cell carcinoma: A meta-analysis.
    Zhou W; Zhang GL
    PLoS One; 2019; 14(10):e0224266. PubMed ID: 31644587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.